PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Neoplasms of genitourinary system among human immunodeficiency virus-infected individuals
Article published in Urologia Polska 2007/60/3.

authors

Zbigniew Jabłonowski, Elżbieta Jabłonowska
I Klinika Urologii Katedry Urologii Uniwersytetu Medycznego w Łodzi
Klinika Chorób Zakaźnych i Hepatologii Uniwersytetu Medycznego w Łodzi

keywords

genitourinary system, neoplasms, HIV, AIDS, diagnosis, treatment

summary

the course of the HIV infection and caused the fall of death rate due to AIDS (Acquired Immunodeficiency Syndrome). Earlier recognized opportunistic infections are currently happening rarely. More aggressive treatment of many diseases such as neoplasmatic diseases are possible thanks to HAART. At present, HIV infected patients are not disqualified from the most complicated interventions such as transplantation of organs or reconstructive operations. It seems, that due to the longer lifetime of HIV infected patients, they will need urological intervention more often. Authors discuss the tumors which are present more often in HIV infected persons and define AIDS (Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer) as well as these which are recognized in HIV infected persons more often but do not define AIDS (testicle tumors, penile cancer, renal cell cancer). We discussed the diagnosis and the treatment of the tumors which incidence grows up with the age (prostate cancer) and for this reason can cause an essential clinical problem in this group of patients . In the era of HAART prognosis concerning the tumors is same in both HIV infected and non HIV infected patients. The treatment applied to the majority of HIV infected patients usually does not differ from this applied to the non HIV infected patients and the results of treatment are comparable in both groups.

references

  1. http://data.unaids.org/Publications/IRC-pub06/epi_update2005_en.pdf
  2. www.pzh.gov.pl/epimeld/hiv_aids/index.htm
  3. Heyns CF, Fisher M: The urological management of the patient with acquired immunodeficiency syndrome. BJU Int 2005, 95, 709-716.
  4. Biggar RJ, Rabkin CS: The epidemiology of AIDS-related neoplasms. Haematol Oncol Clin North Am 1996, 10, 997-1010.
  5. Pollok RCG, Francis N, Cliff S et al: Kaposi�s sarcoma in the kidney. Int J STD AIDS 1995, 6, 289-290.
  6. Kneale BJ, Bishop NL, Britton JP: Kaposi�s sarcoma of the testis. Br J Urol 1993, 72, 116-117.
  7. Lowe FC, Lattimer DG, Metroka CE: Kaposi�s sarcoma of the penis in patients with acquired immunodeficiency syndrome. J Urol 1989, 142, 1475-1477.
  8. Klein LT, Lowe FC: Penile gangrene associated with extensive Kaposi�s sarcoma in patients with the acquired immunodeficiency syndrome. Urology. 1995 Sep, 46 (3), 425-428.
  9. Tirelli U, Bernardi D, Spina M et al: AIDS-related tumors: integrating antiviral and anticancer therapy. Crit Rev Oncol Hematol 2002, 41, 299�315.
  10. Dezube BJ, Pantanowitz L, Aboulafia DM: Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment. AIDS Read 2004, 14, 236-238, 243-244, 251-253.
  11. Koon HB, Bubley GJ, Pantanowitz L et al: Imatinib-induced regression of AIDS-related Kaposi�s sarcoma. J Clin Oncol 2005, 23, 982-989.
  12. Noy A, Scadden DT, Lee J et al: Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi�s sarcoma in a phase III trial, but highlights sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 study group. J Clin Oncol 2005, 23, 1-9.
  13. Beral V, Peterman T, Berkelman R, Jaffe H: AIDS-associated non-Hodgkin lymphoma. Lancet 1991, 337, 805-809.
  14. Knowles DM, Chamulak GA, Subar M et al: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988, 108, 744-753.
  15. Pluda JM, Yarchoan R, Jaffe ES et al: Development of non-Hodgkin�s lymphoma in a cohort of patients with severe immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 1990, 113, 276-282.
  16. Mocroft A, Katlama C, Johnson AM et al: AIDS across Europe, 1994-98: the EuroSIDA study. Lancet 2000, 356, 291-296.
  17. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R: Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein- Barr virus. Blood 1989, 73, 792-799.
  18. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi�s sarcoma- -associated herpesvirus-like DNA sequences in AIDS-related body-cavitybased lymphomas. N Engl J Med 1995, 332, 1186�1191.
  19. Boue F, Gabarre J, Gisselbrechet C: CHOP chemotherapy plus rituximab in HIV patients with high grade lymphoma � results of an ANRS trial. Blood 2002, 22, 470a.
  20. Spina M, Jaeger U, Sparano JA et al: Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide associated in HIV non-Hodgkin�s lymphoma: pooled from results from 3 phase 2 trials. Blood 2005, 105, 1891-1897.
  21. Sparano JA, Lee S, Chen MG et al: Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non- -Hodgkin�s lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). J Clin Oncol 2004,22,1491-1500.
  22. Gabarre J, Azar N, Autran B et al: High-dose chemotherapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet 2000, 355, 1071-1072.
  23. Re A, Cattaneo C, Michieli M et al: High-dose therapy and autologous peripheral- blood stem-cell (PBSC) transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003, 21, 4423-4427.
  24. Bosch FX, Munoz N: The viral etiology of cervical cancer. Virus Res 2002, 89 (2), 183-190.
  25. Gabutti G, Vercelli M, De Rosa M et al: AIDS related neoplasms in Genoa, Italy. Eur J Epidemiol 1995, 11, 609-614.
  26. Goedert J, Cote T, Virgo P et al: Spectrum of AIDS � associated malignant disorders. Lancet 1998, 351, 1833-1839.
  27. Grulich A, Li Y, McDonald A et al: Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002, 16, 1155-1161.
  28. Hentrich MU, Brack NG, Schmid P et al: Testicular germ cell tumors in patients with human immunodeficiency virus infection. Cancer 1996, 77, 2109-2116.
  29. Lyter D, Bryant J, Thackeray R et al: Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1995, 13, 2540-2546.
  30. Powles T, Bower M, Daugaard G et al: Multicenter Study of Human Immunodeficiency Virus � Related Germ Cell Tumors. Journal of Clinical Oncology 2003, 21, 1922-1927.
  31. Frisch M, Biggar R, Engels E et al: Association of cancer with AIDS-related immunosuppression in adults. J Am Med Assoc 2001, 285, 1736-1745.
  32. Wilkinson M, Carroll PR: Testicular carcinoma in patients positive and at risk for human immunodeficiency virus: J Urol 1990, 144, 1157-1159.
  33. Wilson WT, Frenkel E, Vuitch F et al: Testicular tumors in men with human immunodeficiency virus: J Urol 1992, 147, 1038-1040.
  34. Rapley EA, Crockford GP, Teare D et al: Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet 2000, 24, 197-200.
  35. Torres A, Casanova JF, Nistal M et al: Quantification of immunocompetent cells in testicular germ cell tumours. Histopathology 1997, 30, 23-30.
  36. Oliver RT, Leahy M, Ong J: Combined seminoma/non-seminoma should be considered as intermediate grade germ cell cancer (GCC). Eur J Cancer 31A: 1392-1394, 1995
  37. Hyun G, Lowe FC: AIDS and the urologist. Urol Clin North Am 2003 Feb, 30 (1), 101-109
  38. Timmerman JM, Northfelt DW, Small EJ: Malignant germ cell tumors in men infected with the human immunodeficiency virus: Natural history and results of therapy. J Clin Oncol 1995, 13, 1391-1397.
  39. Bernardi D, Salvioni R, Vaccher E et al: Testicular germ cell tumors and human immunodeficiency virus infection: A report of 26 cases � Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995, 13, 2705-2711.
  40. Fizazi K, Amato RJ, Beuzeboc P et al: Germ cell tumors in patients infected by the human immunodeficiency virus. Cancer 2001, 92, 1460-1467.
  41. Burgers JK, Badalament RA, Drago JR: Penile cancer. Clinical presentation, diagnosis and staging. Urol Clin North Am 1992, 19, 247-256.
  42. Nakagawa M, Stites DP, Farhat S et al: T cell proliferative response to human papilloma virus type 16 peptides: relationship to cervical intra-epithelial neoplasia. Clin Diagn Lab Immunol 1996, 3, 205-210.
  43. Takeshita S, Breen EC, Ivashchenko M et al: Induction of IL-6 and IL-10 production by recombinant HIV-1 envelope glycoprotein 41 (gp41) and the THP-1 human monocytic cell line. Cell Immunol 1995, 165, 234-242.
  44. Frisch M, Biggar RJ, Goedert JJ: Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000, 92, 1500-1510.
  45. Lee LK, Dinneen MD, Ahmad S: The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome. BJU Int 2001, 88, 500-510.
  46. Gerber GS: Carcinoma in situ of the penis. J Urol 1994, 151, 829-833.
  47. Harth Y, Hirshowitz B, Kaplan B: Modified topical photodynamic therapy of superficial skin tumor, utilizing aminolevulinic acid, penetration enhancers, red light and hyperthermia. Dermatol Surg 1998, 24, 723-726.
  48. Manfredi R, Sabbatani S, Calza L, Chiodo F: Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: A rare, but intriguing association. Two case reports and literature review. Scand J Infect Dis 2006, 38, 566-570.
  49. Burgi A, Brodine S, Wegner Set al: Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005, 104, 1505-1511.
  50. O�Connor JK, Nedzi LA, Zakris EL: Prostate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literature. Clin Genitourin Cancer 2006, 5, 85-88.
  51. Baynham SA, Katner HP, Cleveland KB: Increased prevalence of renal cell carcinoma with HIV infection. Aids Patient Care STDS 1997, 11, 161-165.

correspondence

I Klinika Urologii Katedry Urologii UM
ul. Żeromskiego 113
90-549 Łódź
tel. (042) 639 35 31
Zby_szek@tlen.pl